Clinical trial

Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or…

NCT00258323 · Case Comprehensive Cancer Center, Other · Completed

Key facts

NCT number NCT00258323
Title Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction Cancer
Official title A Phase II Trial of Pre- and Postoperative Chemoradiotherapy and ZD1839 (IRESSA) Followed by Maintenance ZD1839 in Patients With Locoregionally Advanced Esophageal and Gastroesophageal Junction Carcinoma
Lead sponsor Case Comprehensive Cancer Center, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Esophageal Cancer
Intervention type Drug, Procedure, Radiation
Interventions cisplatin, fluorouracil, Iressa, conventional surgery, radiation therapy
Enrollment 80
Start date Oct 1, 2005
Primary completion Jul 1, 2007
Completion Feb 1, 2010
First posted Nov 24, 2005
Last update posted Sep 30, 2015
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies